Amyris Inc. (AMRS)

3.79
0.07 1.80
NASDAQ : Process Industries
Prev Close 3.86
Open 3.90
Day Low/High 3.74 / 3.95
52 Wk Low/High 1.87 / 6.06
Volume 419.86K
Avg Volume 826.60K
Exchange NASDAQ
Shares Outstanding 105.50M
Market Cap 407.24M
EPS -3.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
6 Stocks Under $10 to Trade for Breakouts

6 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

3 Stocks Improving Performance Of The Chemicals Industry

3 Stocks Improving Performance Of The Chemicals Industry

TheStreet highlights 3 stocks that pushed the Chemicals industry

First Week of March 2016 Options Trading For Amyris (AMRS)

First Week of March 2016 Options Trading For Amyris (AMRS)

Investors in Amyris, Inc. saw new options become available this week, for the March 2016 expiration.

Amyris Announces Early Success Of Muck Daddy(TM), High-Performance Hand Cleaner -- With Initial Pre-Launch Product Shipments Surpassing 3,000 Units

Amyris Announces Early Success Of Muck Daddy(TM), High-Performance Hand Cleaner -- With Initial Pre-Launch Product Shipments Surpassing 3,000 Units

Teams Up With Former Chicago Bears Linebacker Brian Urlacher to Kick Off Official Product Launch and Celebrate Mechanic Appreciation Day in Chicago July 26, 2015

Amyris (AMRS) Stock Spike on New Food Ingredients Collaboration Agreement

Amyris (AMRS) Stock Spike on New Food Ingredients Collaboration Agreement

Amyris (AMRS) shares are higher following the announcement of a new multi-year agreement with a global food ingredients supplier.

Amyris Announces Multi-Year, Multi-Million-Dollar Agreement With Global Food Ingredients Supplier

Amyris Announces Multi-Year, Multi-Million-Dollar Agreement With Global Food Ingredients Supplier

Marks Amyris's First Collaboration Agreement in Food Sector

Amyris Announces Update And Correction Regarding Its SMA Industria Quimica Joint Venture With Usina Sao Martinho

Amyris Announces Update And Correction Regarding Its SMA Industria Quimica Joint Venture With Usina Sao Martinho

SMA Joint Venture Is Ongoing and Decision Regarding Restarting Construction of Plant Has No Impact on Amyris Revenue Expectations or Short-Term Growth Plans

Amyris Announces Successful Completion Of Volkswagen Renewable Diesel Evaluation Program

Amyris Announces Successful Completion Of Volkswagen Renewable Diesel Evaluation Program

Confirms Outstanding Performance and Environmental Benefits of Amyris's Renewable Diesel Under Real-World Driving Conditions

Amyris & Dinaco Announce Exclusive Re-Seller Agreement For Neossance(R) Cosmetic Ingredients In Brazil

Amyris & Dinaco Announce Exclusive Re-Seller Agreement For Neossance(R) Cosmetic Ingredients In Brazil

Expands Distribution of Amyris's High-Performance Emollients Into Growing Market for Renewably-Sourced Personal Care Products

Insider Trading Alert - AMRS, MKTX And CERN Traded By Insiders

Insider Trading Alert - AMRS, MKTX And CERN Traded By Insiders

Stocks with insider trader activity include AMRS, MKTX and CERN

Amyris Reports First Quarter 2015 Financial Results

Amyris Reports First Quarter 2015 Financial Results

Achieves Positive Cash Flow of $1.7 Million for Quarter and Over $30 Million of Cash Revenue Inflows

Amyris Hosts Event To Preview Launch Of Biossance(TM) Brand

Amyris Hosts Event To Preview Launch Of Biossance(TM) Brand

Marks Debut of Company's First Consumer Skin Care Product

Amyris & Squalan Natural Health Partner To Accelerate Development And Sales Of Neossance(R) Personal Care Products

Amyris & Squalan Natural Health Partner To Accelerate Development And Sales Of Neossance(R) Personal Care Products

Combination of Amyris's Squalane Production Capabilities and Squalan's Formulation Expertise Aims to Expand Neossance Product Offerings

Amyris & Genome Compiler Partner To Commercialize DNA Construction Software Services For The Pharma And Biotech Industries

Amyris & Genome Compiler Partner To Commercialize DNA Construction Software Services For The Pharma And Biotech Industries

Combination of Amyris's DNA Construction Capabilities and Genome Compiler's Computer-Aided DNA Design Software Aims to Accelerate Development of Therapeutics

Amyris Secures Equity Financing Commitment

Amyris Secures Equity Financing Commitment

Agreement Provides Flexible Access to Growth Capital

3 Stocks Pushing The Chemicals Industry Lower

3 Stocks Pushing The Chemicals Industry Lower

TheStreet highlights 3 stocks pushing the Chemicals industry lower today.

Amyris To Announce Fourth Quarter And Full Year 2014 Financial Results On Tuesday, February 24, 2015

Amyris To Announce Fourth Quarter And Full Year 2014 Financial Results On Tuesday, February 24, 2015

Amyris Executives to Present at Upcoming Investor Conferences

TheStreet Quant Rating: E+ (Sell)